Diabetes, Obesity and Metabolism

1. Diabetes Obes Metab22 Jul 2026

   Association Between Time in Range and Advanced Cardiovascular‐Kidney‐Metabolic Syndrome in Older Adults With Type 2 Diabetes

   Cross-sectional studyTechnology

2. Diabetes Obes Metab22 Jul 2026

   Closer Association of Liver Stiffness Than Liver Fat Content With Imaging‐Derived Neurovascular Coupling in a Metabolic Dysfunction‐Associated Steatotic Liver Disease Cohort

   Cross-sectional studyLipids & liver

3. Diabetes Obes Metab22 Jul 2026

   Joint Trajectories of Physical Activity and Depressive Symptoms and Incident Cardiometabolic Multimorbidity: A Multi‐Cohort Study

   Cohort studyT2D & other

4. Diabetes Obes Metab21 Jul 2026

   Clinical and Economic Burden of Obesity and Cardiovascular Disease Among Medicare Fee‐For‐Service Beneficiaries

   Cohort studyObesity

5. Diabetes Obes Metab21 Jul 2026

   Antecedent of Pregnancy‐Related Cardiometabolic Complication and Risk of Cardiovascular Disease Among Women With Type 2 Diabetes

   Cohort study

6. Diabetes Obes Metab21 Jul 2026

   Diabetic Foot Ulcers Are Clinical Marker of Disease Burden in People With Diabetes and Heart Failure

   Cohort studyComplications

7. Diabetes Obes Metab21 Jul 2026

   Predictive Performance of Seven Clinical Surrogates of Visceral Adipose Tissue for Cardiovascular Mortality: A Sub‐Analysis of 102 385 Adults From the Mexico City Prospective Study

   Cohort studyObesity

8. Diabetes Obes Metab21 Jul 2026

   Safety Signals of GLP ‐1 Receptor Agonists: A Multi‐Method Pharmacovigilance Analysis of FAERS (2018–2025) With Sensitivity‐Stratified Prioritisation, Notoriety‐Bias Assessment, and Cross‐Database Validation

   Diagnostic or prognostic studyT2D & other

9. Diabetes Obes Metab20 Jul 2026

   Looking Beyond Glycaemic Control: Real‐World 12‐Month Cardiometabolic and Retinopathy Outcomes Following Omnipod 5 Initiation in People With Type 1 Diabetes

   Cohort studyTechnology

10. Diabetes Obes Metab20 Jul 2026

    Postprandial Glycemic Control With Automated Insulin Delivery With Control‐ IQ Technology: The Impact of Meal Composition

    Cohort study

11. Diabetes Obes Metab20 Jul 2026

    A Real‐World Cohort Study on the Association of the Use of Sodium‐Glucose Cotransporter‐2 Inhibitor With the Incidence of Chronic Kidney Disease ( CKD ) in Patients With Type 2 Diabetes Mellitus Without CKD Using the SingHealth Diabetes Registry

    Cohort studyT2D & other

12. Diabetes Obes Metab19 Jul 2026

    Age of Type 1 Diabetes Onset and Dementia Risk: A Swedish Nationwide, Register‐Based Cohort Study

    Cohort studyT1D

13. Diabetes Obes Metab19 Jul 2026

    Changes in Muscle Mass and the Risk of Liver‐Related Events: A Prospective Cohort Study

    Cohort studyLipids & liver

14. Diabetes Obes Metab19 Jul 2026

    Durability and Safety of Imeglimin as an Add‐On to DPP ‐4 Inhibitors in Japanese Type 2 Diabetes: The 104‐Week FAMILIAR Trial

    Randomized controlled trialT2D & other

15. Diabetes Obes Metab19 Jul 2026

    Efficacy and Safety of iGlarLixi Versus IDegAsp by Baseline Age, Disease Duration and HbA1c in Chinese People With Type 2 Diabetes: Post Hoc Analyses of the Soli‐D Study

    Secondary analysisT2D & other

16. Diabetes Obes Metab19 Jul 2026

    Insulin, Semaglutide and Dapagliflozin in Adults With Type 1 Diabetes: Design and Methods of Triple Therapy for Type 1 Diabetes ( TTT1 )—An International Phase 3 Clinical Trial

    Trial designT1D

17. Diabetes Obes Metab16 Jul 2026

    Association of Maternal Overweight/Obesity Metabolic Phenotypes With Longitudinal Foetal Anthropometric Measurements

    Cohort studyObesity

18. Diabetes Obes Metab16 Jul 2026

    Clinical Outcomes for Newly Diagnosed Diabetes Patients in Korea: A National Health Insurance Data

    Cohort studyT2D & other

19. Diabetes Obes Metab16 Jul 2026

    Effectiveness of Telehealth Low‐Carbohydrate Intervention in Preventing Chronic Kidney Disease: A Real‐World, Retrospective, Matched Cohort Study

    Cohort studyT2D & other

20. Diabetes Obes Metab15 Jul 2026

    Efficacy of DPP ‐4 Inhibitors on Seated and Ambulatory Blood Pressure in Type 2 Diabetes Mellitus

    Meta-analysisT2D & other

21. Diabetes Obes Metab14 Jul 2026

    Association of Variability of Monthly Continuous Glucose Monitoring‐Derived Metrics With Diabetic Kidney Disease in Type 1 Diabetes

    Cross-sectional studyT1D

22. Diabetes Obes Metab14 Jul 2026

    Effects of GLP ‐1 Receptor Agonists and Dual GIP / GLP ‐1 Receptor Agonists on Inflammatory and Metabolic Biomarkers in Type 2 Diabetes: A Systematic Review and Meta‐Analysis

    Meta-analysisT2D & other

23. Diabetes Obes Metab14 Jul 2026

    MetaboHealth and Metabolic Vulnerability Index as Risk Factors for Cardio–Renal–Metabolic Multimorbidity: A Large‐Scale Prospective Cohort Study

    Cohort study

24. Diabetes Obes Metab13 Jul 2026

    Comparative Efficacy of Insulin Delivery Modalities on Glycaemic Control in Adults With Type 2 Diabetes: A Systematic Review and Network Meta‐Analysis

    Meta-analysisT2D & other

25. Diabetes Obes Metab13 Jul 2026

    Comparison of Diluted Insulin (U10) Versus Standard (U100) Insulin in Automated Insulin Delivery Systems: Reducing Time Below Range in Young Children

    Cohort studyTechnology

26. Diabetes Obes Metab13 Jul 2026

    Fractional Excretion of Total Protein and Long‐Term Kidney Outcomes in Patients With Biopsy‐Proven Diabetic Nephropathy: The N‐ BDN Study

    Cohort studyComplications

27. Diabetes Obes Metab13 Jul 2026

    Immune Cell‐Stratified Regulatory Contexts Associated With BMI ‐Related Multi‐System Disease Risk: A Cell‐Stratified Mendelian Randomization Study Using Single‐Cell eQTL Data

    Research articleObesity

28. Diabetes Obes Metab13 Jul 2026

    Renal Impairment Does Not Affect Pharmacokinetics, Safety or Tolerability of Zenagamtide

    Research articleT2D & other

29. Diabetes Obes Metab13 Jul 2026

    Safety Profile of Tirzepatide in Real‐World Clinical Practice: A Pharmacovigilance Study Using the FAERS Database

    Cohort studyT2D & other

30. Diabetes Obes Metab13 Jul 2026

    Treatment Patterns and Experienced Effects of Semaglutide for Weight Management Among Adult Users in Denmark: A Community Pharmacy‐Based Cross‐Sectional Survey

    Cross-sectional studyObesity

31. Diabetes Obes Metab9 Jul 2026

    Continuous Intraperitoneal Insulin Infusion for People With Type 1 Diabetes: A Literature Review and International Position Statement

    Guideline or statementTechnology

32. Diabetes Obes Metab9 Jul 2026

    Efficacy and Safety of SGLT2 Inhibitors and GLP ‐1 Receptor Agonists on Ventricular Arrhythmias and Cardiovascular Events: A Disease‐Stratified Network Meta‐Analysis

    Meta-analysisT2D & other

33. Diabetes Obes Metab9 Jul 2026

    Efficacy and Safety of Anti‐Obesity Medications for Weight Loss Maintenance in Adults With Overweight or Obesity: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials

    Meta-analysisObesity

34. Diabetes Obes Metab9 Jul 2026

    Leisure‐Time Physical Activity on Age‐Modelled Trajectories of Body Mass Index and Obesity Risk Throughout Life: Multivariable Regression and Mendelian Randomization Analyses Using Electronic Health Record Data From the CORDELIA ‐Catalunya Study

    Cohort studyObesity

35. Diabetes Obes Metab8 Jul 2026

    Efficacy and Safety of Ion Channel Modulators in Painful Diabetic Neuropathy

    Meta-analysisComplications

36. Diabetes Obes Metab8 Jul 2026

    Baseline Computed Tomography Coronary Angiography and Polygenic Risk Profiles in Adults With Type 2 Diabetes: A Cross‐Sectional Analysis From the VOLTAIRE Study

    Cross-sectional studyT2D & other

37. Diabetes Obes Metab8 Jul 2026

    Continuous Glucose Monitoring and Hypoglycaemia Risk During Paediatric DKA Treatment in the PICU : A Retrospective Cohort Study

    Cohort studyTechnology

38. Diabetes Obes Metab8 Jul 2026

    Early Worsening of Diabetic Retinopathy Following Initiation of Hybrid Closed‐Loop/Automated Insulin Delivery Systems in Type 1 Diabetes: A Systematic Review and Structured Study‐Level Synthesis

    Meta-analysisT1D

39. Diabetes Obes Metab8 Jul 2026

    Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP ‐1 Receptor Agonists

    Cohort studyT2D & other

40. Diabetes Obes Metab8 Jul 2026

    Real‐World Use of Semaglutide for Weight Management: Dose Titration, Discontinuation Patterns and Weight Changes

    Cohort studyObesity

All 2,200 Briefs in ExploreShowing Briefs 201–240 of 2,200, newest first